Ray Esclamado was named the Chief of Duke’s Division of
Otolaryngology - Head and Neck Surgery in January 2006.
Dr. Esclamado comes to Duke University Medical Center from
the Cleveland Clinic Lerner College of Medicine of Case Western
Reserve University, where he served as Professor of Surgery. He
also served as Vice Chairman of the Head and Neck Institute of
the Cleveland Clinic and as Head of the Section of Head and
Neck Surgery within the Institute since 1996.
Known for his expertise in the care and management of
patients with both benign and malignant tumors of the head and
neck, Dr. Esclamado will maintain this clinical focus at Duke
University. His practice is open to all patients desiring or
requiring advanced care for the entire spectrum of head and
neck surgical disorders. This includes patients with cancer of
the head and neck, including the nose and sinuses, salivary
glands, mouth, throat, voicebox, and thyroid gland, and benign
tumors of nerves, thyroid and parathyroid glands,
paragangliomas, congenital or other rare tumors encountered in
the head and neck. Many of these patients will be cared for in
a multidisciplinary format, in order to provide the best
outcomes for the patient.
Dr. Esclamado has 16 years experience in the education and
training of resident physicians in all aspects of head and neck
surgery. As Chief, he plan to enhance the Department of
Surgery’s clinical programs along with the translational and
evidence based outcome studies that are necessary to develop
state of the art care for patients. He anticipates that these
efforts will result in a resident training experience that will
produce the future leaders in Otolaryngology Head and Neck
Surgery.
Dr. Esclamado received his MD degree from the University of
California, Davis in 1983, and then completed a residency in
Otolaryngology Head and Neck Surgery at the University of
Washington Affiliated Hospitals in 1989. From 1989 to 1996 he
was on the faculty of the Department of OHNS at the University
of Michigan, and served as the Director of the Head and Neck
Oncology Program.